Recombinant Human TBC1D1 Protein，His

TBC1D1, a member of the TBC (Tre-2/BUB2/CDC16) domain-containing protein family, has garnered significant attention in recent years due to its critical role in regulating various cellular processes, particularly those associated with metabolism and insulin signaling. This protein is primarily localized in the cytoplasm and has been implicated in the modulation of GLUT4 translocation, which is essential for glucose uptake in muscle and adipose tissues. Given the increasing prevalence of metabolic disorders such as type 2 diabetes and obesity, understanding the molecular mechanisms underlying TBC1D1 function is essential. Research has shown that TBC1D1 acts as a GTPase-activating protein (GAP) for Rab GTPases, which are key modulators of intracellular vesicle trafficking. Dysregulation of TBC1D1 has been linked to impaired insulin-stimulated glucose uptake, making it a potential target for therapeutic interventions. Numerous studies have focused on characterizing its protein interactions and post-translational modifications, as these factors are crucial in determining TBC1D1's functional outcomes. Moreover, the exploration of TBC1D1's role in muscle and fat cell physiology continues to yield insights into its contributions to systemic metabolic health. The investigation of recombinant TBC1D1 protein in various experimental systems has paved the way for further elucidation of its biological roles and downstream effects, underscoring its importance in the context of metabolic regulation and disease. Through ongoing research efforts, TBC1D1 is emerging as a promising candidate for developing novel strategies aimed at treating metabolic diseases, highlighting the need for continued exploration of its mechanisms and applications in biomedical science.